ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI

August 27, 2010

Oncology Nurse “Cinderella’s” Need Specialty Status

November 23, 1974

NCI Proposes Moving Organ Systems coordinating Center Activities In House, Dispersing Grants

October 16, 1987

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991

Prostatectomy Lowers Death Risk Compared to Watchful Waiting

April 29, 2011